162 related articles for article (PubMed ID: 26672899)
1. Analysis of RNA metabolism in peripheral WBCs of TDP-43 KI mice identifies novel biomarkers of ALS.
Hasegawa M; Hara-Miyauchi C; Ohta H; Sakimura K; Okano H; Okano HJ
Neurosci Res; 2016 May; 106():12-22. PubMed ID: 26672899
[TBL] [Abstract][Full Text] [Related]
2. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
3. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
4. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
5. Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics.
Kojima Y; Kasai T; Noto YI; Ohmichi T; Tatebe H; Kitaoji T; Tsuji Y; Kitani-Morii F; Shinomoto M; Allsop D; Teramukai S; Mizuno T; Tokuda T
PLoS One; 2021; 16(11):e0260323. PubMed ID: 34843548
[TBL] [Abstract][Full Text] [Related]
6. Neuronal Expression of UBQLN2
Picher-Martel V; Renaud L; Bareil C; Julien JP
Mol Neurobiol; 2019 Jul; 56(7):4680-4696. PubMed ID: 30377984
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 levels are higher in platelets from patients with sporadic amyotrophic lateral sclerosis than in healthy controls.
Hishizawa M; Yamashita H; Akizuki M; Urushitani M; Takahashi R
Neurochem Int; 2019 Mar; 124():41-45. PubMed ID: 30578840
[TBL] [Abstract][Full Text] [Related]
8. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death.
Nagahara Y; Shimazawa M; Ohuchi K; Ito J; Takahashi H; Tsuruma K; Kakita A; Hara H
J Neurosci Res; 2017 Aug; 95(8):1647-1665. PubMed ID: 27935101
[TBL] [Abstract][Full Text] [Related]
9. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
10. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
11. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
Koyama A; Sugai A; Kato T; Ishihara T; Shiga A; Toyoshima Y; Koyama M; Konno T; Hirokawa S; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
Nucleic Acids Res; 2016 Jul; 44(12):5820-36. PubMed ID: 27257061
[TBL] [Abstract][Full Text] [Related]
12. ALS-linked TDP-43
Watanabe S; Oiwa K; Murata Y; Komine O; Sobue A; Endo F; Takahashi E; Yamanaka K
Mol Brain; 2020 Jan; 13(1):8. PubMed ID: 31959210
[TBL] [Abstract][Full Text] [Related]
13. Mutation in the RRM2 domain of TDP-43 in Amyotrophic Lateral Sclerosis with rapid progression associated with ubiquitin positive aggregates in cultured motor neurons.
Maurel C; Madji-Hounoum B; Thepault RA; Marouillat S; Brulard C; Danel-Brunaud V; Camdessanche JP; Blasco H; Corcia P; Andres CR; Vourc'h P
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):149-151. PubMed ID: 28705014
[TBL] [Abstract][Full Text] [Related]
14. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
[TBL] [Abstract][Full Text] [Related]
15. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 in the skin of amyotrophic lateral sclerosis patients.
Abe K; Ohkubo T; Yokota T
J Med Dent Sci; 2017; 64(1):9-17. PubMed ID: 28367944
[TBL] [Abstract][Full Text] [Related]
17. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
18. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
[TBL] [Abstract][Full Text] [Related]
19. Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins.
Watanabe S; Kaneko K; Yamanaka K
J Biol Chem; 2013 Feb; 288(5):3641-54. PubMed ID: 23235148
[TBL] [Abstract][Full Text] [Related]
20. Altered astrocytic expression of TDP-43 does not influence motor neuron survival.
Haidet-Phillips AM; Gross SK; Williams T; Tuteja A; Sherman A; Ko M; Jeong YH; Wong PC; Maragakis NJ
Exp Neurol; 2013 Dec; 250():250-9. PubMed ID: 24120466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
